Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

11/19/04 FDA Approves Tarceva- For Patients with Advanced Non-Small Cell Lung Cancer; Only Targeted EGFR Therapy Shown to Improve Survival in Advanced Non-Small Cell Lung Cancer        

11/16/04 Post-Therapy Damage Seen on MRI Scans of Medulloblastoma Patients Can Be Mistaken for New Tumors        

11/16/04 On-line flow cytometry for real-time surgical guidance.        

11/16/04 Erlotinib (Tarceva®) Produces Responses in Glioblastoma Multiforme        

11/15/04 Gala to benefit the Brain Tumor Society        

11/14/04 Brain tumour detection advances        

11/12/04 Tarceva® Produces Responses in Recurrent Glioblastoma Multiforme        

11/11/04 Educational attainment among survivors of childhood cancer: a population-based cohort study in Denmark.        

11/11/04 SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.        

11/11/04 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.        

11/11/04 Dexamethasone mediated inhibition of local IL-2 immunotherapy is dose dependent in experimental brain tumors.        

11/11/04 Correlation of N-cadherin expression in high grade gliomas with tissue invasion.        

11/11/04 X-rays Reveal Details of Cancer Protein        

11/11/04 New gene target found for common brain tumors in children        

11/11/04 Ecopia Named One of Canada's Top Ten for a Second Year        

11/11/04 A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma.        

11/11/04 Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment.        

11/11/04 Intracranial meningiomas developing at long intervals following low-dose X-ray irradiation of the head.        

11/11/04 Temozolomide for the treatment of recurrent supratentorial glioma: results of a compassionate use program in Belgium.        

---

Displaying Stories 4881 to 4900 of 7670
Previous 20           Next 20